Safety issues in the management of autoimmune hepatitis

Expert Opin Drug Saf. 2008 May;7(3):319-33. doi: 10.1517/14740338.7.3.319.

Abstract

Background: Prednisone and azathioprine are effective in the treatment of autoimmune hepatitis, but diverse side effects can diminish their net benefit.

Objectives: Describe the frequency and nature of these side effects and propose management strategies to minimize their impact.

Methods: Pertinent articles published from 1970 to 2007 were identified by Medline search and through a personal library.

Results: Medication is prematurely discontinued in 13% of patients mainly because of cosmetic changes, cytopenia, or osteopenia. Populations at high risk are the elderly, those with pre-existent co-morbidities, patients with near-zero thiopurine methyltransferase activity, individuals who are treatment-dependent, pregnant women, and asymptomatic patients who are over-treated.

Conclusions: Proper patient selection, effective pre-treatment counseling, preemptive protective measures, realistic treatment objectives, and early identification of problematic patients can reduce complications. Individualized dosing schedules and the emergence of non-steroidal medications are realistic expectations.

Publication types

  • Review

MeSH terms

  • Azathioprine* / administration & dosage
  • Azathioprine* / adverse effects
  • Azathioprine* / therapeutic use
  • Drug Therapy, Combination
  • Glucocorticoids* / administration & dosage
  • Glucocorticoids* / adverse effects
  • Glucocorticoids* / therapeutic use
  • Hepatitis, Autoimmune / drug therapy*
  • Humans
  • Immunosuppressive Agents* / administration & dosage
  • Immunosuppressive Agents* / therapeutic use
  • Patient Selection
  • Prednisone* / administration & dosage
  • Prednisone* / adverse effects
  • Prednisone* / therapeutic use

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Azathioprine
  • Prednisone